Skip to main content
. Author manuscript; available in PMC: 2021 Aug 30.
Published in final edited form as: J Tissue Eng Regen Med. 2011 Feb 24;6(2):144–154. doi: 10.1002/term.408

Figure 1.

Figure 1.

Experimental set-up for inhibiting MMP activity in different cell types. (A) GM6001 and a synthetic MMP-13 inhibitor were added exogenously into the media and then administered to cells that were encapsulated in crosslinked PEGDA through UV photopolymerization. (B) The four different conditions of this study included administering MMP inhibitors to MSCs and OA chondrocytes cultured in chondrogenic medium with TGFβ1 (CGMT) and normal chondrocytes (CC) and OA chondrocytes cultured in chondrocyte growth medium (CCM)